EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Genome-wide screening and functional validation of methylation barriers near promoters

Jingmin Shu, Jaroslav Jelinek, Hai Chen, Yan Zhang, Taichun Qin, Ming Li, Li Liu iD, Jean-Pierre J Issa iD

Nucleic Acids Research · 2024

DOI: 10.1093/nar/gkae302 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Jingmin Shu und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Health Solutions, Arizona State University, Phoenix, AZ, USA. Hauptthemen laut MEDLINE: Colorectal Neoplasms, DNA Methylation, Promoter Regions, Genetic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NLM NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CpG islands near promoters are normally unmethylated despite being surrounded by densely methylated regions. Aberrant hypermethylation of these CpG islands has been associated with the development of various human diseases. Although local genetic elements have been speculated to play a role in protecting promoters from methylation, only a limited number of methylation barriers have been identified. In this study, we conducted an integrated computational and experimental investigation of colorectal cancer methylomes. Our study revealed 610 genes with disrupted methylation barriers. Genomic sequences of these barriers shared a common 41-bp sequence motif (MB-41) that displayed homology to the chicken HS4 methylation barrier. Using the CDKN2A (P16) tumor suppressor gene promoter, we validated the protective function of MB-41 and showed that loss of such protection led to aberrant hypermethylation. Our findings highlight a novel sequence signature of cis-acting methylation barriers in the human genome that safeguard promoters from silencing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsDNA MethylationPromoter Regions, GeneticAnimalsHumansCell Line, TumorCpG IslandsCyclin-Dependent Kinase Inhibitor p16Genome, HumanNucleotide MotifsChickensGenome-Wide Association Study

Substanzen

Cyclin-Dependent Kinase Inhibitor p16

Autor:innen und Institutionen

  • College of Health Solutions, Arizona State University, Phoenix, AZ, USA.
  • Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, AZ, USA.
  • Fels Institute for Cancer Research, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, USA.
  • Cooper Medical School at Rowan University, Camden, NJ 08103, USA.
  • Coriell Institute for Medical Research, Camden, NJ 08103, USA.
  • Phoenix VA Health Care System, Phoenix, AZ 85012, USA.

ORCID-Profile: Li Liu, Jean-Pierre J Issa

Förderung

  • NCI NIH HHS
  • NLM NIH HHS
  • NIDDK NIH HHS
  • NIH HHS
  • NIH

Zitieren

APA

Shu, J., Jelinek, J., Chen, H., Zhang, Y., Qin, T., Li, M., Liu, L., & Issa, J. J. (2024). Genome-wide screening and functional validation of methylation barriers near promoters. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae302

Vancouver

Shu J, Jelinek J, Chen H, Zhang Y, Qin T, Li M, et al. Genome-wide screening and functional validation of methylation barriers near promoters. Nucleic Acids Research. 2024. doi:10.1093/nar/gkae302

BibTeX
@article{Shu2024,
  author = {Shu, Jingmin and Jelinek, Jaroslav and Chen, Hai and Zhang, Yan and Qin, Taichun and Li, Ming and Liu, Li and Issa, Jean-Pierre J},
  title = {Genome-wide screening and functional validation of methylation barriers near promoters},
  journal = {Nucleic Acids Research},
  year = {2024},
  doi = {10.1093/nar/gkae302}
}
Kostenlos starten →